-
201
An NR2B-Dependent Decrease in the Expression of trkB Receptors Precedes the Disappearance of Dopaminergic Cells in Substantia Nigra in a Rat Model of Presymptomatic Parkinson's Dis...
Published 2012-01-01“…Parkinson's Disease…”
Get full text
Article -
202
Detection of Phosphorylated Alpha-Synuclein in the Muscularis Propria of the Gastrointestinal Tract Is a Sensitive Predictor for Parkinson’s Disease
Published 2020-01-01“…Parkinson's Disease…”
Get full text
Article -
203
Cognitive Rehabilitation for Executive Dysfunction in Parkinson's Disease: Application and Current Directions
Published 2012-01-01“…Parkinson's Disease…”
Get full text
Article -
204
MRI Correlates of Parkinson’s Disease Progression: A Voxel Based Morphometry Study
Published 2015-01-01“…Parkinson's Disease…”
Get full text
Article -
205
Nonpharmacological Modulation of Chronic Inflammation in Parkinson’s Disease: Role of Diet Interventions
Published 2019-01-01“…Parkinson's Disease…”
Get full text
Article -
206
Spectral and coupling characteristics of somatosensory cortex and centromedian thalamus differentiate between pre- and inter-ictal 5–9 Hz oscillations in a genetic rat model of abs...
Published 2025-02-01“…Neurobiology of Disease…”
Get full text
Article -
207
LSVT LOUD and LSVT BIG: Behavioral Treatment Programs for Speech and Body Movement in Parkinson Disease
Published 2012-01-01“…Parkinson's Disease…”
Get full text
Article -
208
Quantitative Analysis of Postural Instability in Patients with Parkinson’s Disease
Published 2021-01-01“…Parkinson's Disease…”
Get full text
Article -
209
Dynamic Changes in the Nigrostriatal Pathway in the MPTP Mouse Model of Parkinson’s Disease
Published 2017-01-01“…Parkinson's Disease…”
Get full text
Article -
210
L-Dopa Pharmacokinetic Profile with Effervescent Melevodopa/Carbidopa versus Standard-Release Levodopa/Carbidopa Tablets in Parkinson’s Disease: A Randomised Study
Published 2015-01-01“…Parkinson's Disease…”
Get full text
Article -
211
Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson’s Disease Receiving ≥2000 mg Daily Dose of Levodopa
Published 2020-01-01“…Parkinson's Disease…”
Get full text
Article -
212
Assessment of Atrial Conduction Times in Patients with Newly Diagnosed Parkinson’s Disease
Published 2018-01-01“…Parkinson's Disease…”
Get full text
Article -
213
Genetic Profile, Environmental Exposure, and Their Interaction in Parkinson’s Disease
Published 2016-01-01“…Parkinson's Disease…”
Get full text
Article -
214
Diagnostic Validation for Participants in the Washington State Parkinson Disease Registry
Published 2018-01-01“…Parkinson's Disease…”
Get full text
Article -
215
Dance Is an Accessible Physical Activity for People with Parkinson’s Disease
Published 2021-01-01“…Parkinson's Disease…”
Get full text
Article -
216
Visual Hallucinations as Incidental Negative Effects of Virtual Reality on Parkinson’s Disease Patients: A Link with Neurodegeneration?
Published 2015-01-01“…Parkinson's Disease…”
Get full text
Article -
217
Enhancement of Executive Functions but Not Memory by Multidomain Group Cognitive Training in Patients with Parkinson’s Disease and Mild Cognitive Impairment: A Multicenter Randomiz...
Published 2020-01-01“…Parkinson's Disease…”
Get full text
Article -
218
Salivary Acetylcholinesterase Activity Is Increased in Parkinson’s Disease: A Potential Marker of Parasympathetic Dysfunction
Published 2015-01-01“…Parkinson's Disease…”
Get full text
Article -
219
Whole transcriptome analysis of unmutated sporadic ALS patients' peripheral blood reveals phenotype-specific gene expression signature
Published 2025-03-01“…Neurobiology of Disease…”
Get full text
Article -
220
Prevalence of Fabry Disease among Patients with Parkinson’s Disease
Published 2022-01-01“…Parkinson's Disease…”
Get full text
Article